Increase in Smokers and Decrease in E-Cigarette Use in Ireland

Dec.15.2022
Increase in Smokers and Decrease in E-Cigarette Use in Ireland
Ireland's smoking rate increased from 17% to 18%, while e-cigarette use dropped from 5% to 3%.

According to the latest survey released in Ireland, the smoking rate has increased from 17% in 2019 to 18%. Meanwhile, the e-cigarette usage rate has decreased from the record 5% in 2019 to 3% this year. NNA Ireland, the new nicotine alliance, is questioning how this has happened.


The Healthy Ireland Survey is an annual survey that targets a representative sample of the population aged 15 and over living in Ireland. Typically, the sample size is around 7,500 people.


The key findings of the 2022 Healthy Ireland Survey are summarized as follows:


. According to recent surveys, 18% of the population currently smoke, with 14% smoking daily and 4% smoking occasionally. The age group most likely to smoke is 25-34, as consistently found in surveys conducted between 2015-2019.


Among all age groups, men are more likely to smoke than women, with the greatest difference being between the ages of 25-34.


Among this age group, over one-third (34%) of men and 14% of women are smokers. In the 25-34 age group, over one-quarter (27%) of men smoke daily, compared to 10% of women of the same age. The equivalent percentage in the 2021 survey was 20% for men and 16% for women.


In the past 12 months, 46% of smokers attempted to quit smoking. Of those who attempted to quit smoking in the past 12 months, 23% were successful.


Three percent of people have used electronic cigarettes, while another three percent said they had tried them in the past but no longer use them. The usage of electronic cigarettes is highest among people under the age of 25, with six percent currently using them in this age group.


Can we attribute this situation to the consistent opposition to e-cigarettes by Ireland's tobacco control? Perhaps not," said NNA Ireland. "We can ask why the smoking rate in the UK was 13.3% in 2021, with an e-cigarette usage rate of 7.7%, which is much better than ours. Is the difference in e-cigarette policies a factor?


According to NNA Ireland, electronic cigarettes are seen as a positive development in the UK. The organization quoted a statement saying that the decrease in the percentage of smokers may be attributed in part to the increase in electronic cigarette use. Data from the Opinion and Lifestyle Survey showed that in 2021, there was an increase in the number of people using electronic cigarette devices regularly and the age group with the highest usage rates was between 16 and 24 years old.


Mark Murphy, spokesperson for the Irish Heart Foundation, commented on these figures, saying: "Unfortunately, we have not seen any further progress this year in reducing smoking rates among the general population, meaning nearly one-fifth of the country continues to smoke. However, the most concerning trend is the significant increase in smoking rates among the 25-34 age group since last year. It is clear that we cannot continue on the current trajectory and the government needs to do more to prevent smoking and encourage those who already smoke to quit.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
Australia Plans Tougher Penalties for Illicit Tobacco and Vape Crime
Australia Plans Tougher Penalties for Illicit Tobacco and Vape Crime
The Australian government is preparing a new crackdown on the illicit tobacco market, including stronger penalties, expanded police surveillance powers and tougher asset seizure measures.
Mar.19 by 2FIRSTS.ai
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
The U.S. Food and Drug Administration has told vape manufacturer Fontem US that it does not presently intend to take enforcement action against the company’s Zone nicotine pouches while litigation over the agency’s handling of the application remains unresolved.
Apr.07 by 2FIRSTS.ai
Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework
Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework
A new Alberta bill aimed at reducing vaping rates, especially among young people, is moving into the legislative process. Bill 208, the Vaping Reduction Act, was introduced by United Conservative Party MLA Chelsae Petrovic and appears to build on the province’s existing Tobacco, Smoking and Vaping Reduction Act. Early reporting suggests the bill could focus on disposable vapes and impose further limits on youth access to vaping products.
Apr.15 by 2FIRSTS.ai
2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts held its second U.S. PMTA compliance training in Shenzhen, providing a systematic overview of the U.S. regulatory framework for e-cigarettes and corporate compliance strategies. Nearly 20 industry professionals from manufacturing, e-liquid and supply-chain companies attended. Participants who passed the exam received compliance certification. Registration for the third training session will open soon, alongside customized corporate training programs.
Mar.09
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24